Anzeige
Mehr »
Lynx Broker
Login
Sonntag, 20.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0Q2FS ISIN: NO0010405640 Ticker-Symbol: 4QG 
Stuttgart
18.10.19
16:12 Uhr
2,525 Euro
-0,060
-2,32 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
PCI BIOTECH HOLDING ASA Chart 1 Jahr
5-Tage-Chart
PCI BIOTECH HOLDING ASA 5-Tage-Chart

Aktuelle News zur PCI BIOTECH HOLDING Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrPCI Biotech Holding ASA: PCI Biotech: Mandatory notification regarding trade of shares140Stocken Invest AS, a wholly owned company by Lars Viksmoen, has on 18 October 2019 transferred 12,966 shares in PCI Biotech Holding ASA ("PCI Biotech") to Lars Viksmoen, board member of PCI Biotech...
► Artikel lesen
09.09.PCI Biotech Holding ASA: PCI Biotech: Capital increase registered and listing of new shares161Oslo, Norway, 9 September 2019. Reference is made to the previous announcements by PCI Biotech Holding ASA ("PCI Biotech" or the "Company") in respect of the issuance of 40,000 new shares following...
► Artikel lesen
PCI BIOTECH HOLDING Aktien ab 5,80 Euro handeln - Ohne versteckte Kosten!
04.09.PCI Biotech Holding ASA: PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase share capital209Oslo (Norway), 4 September 2019 - Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the "Company"). 1....
► Artikel lesen
29.08.PCI Biotech Holding ASA: PCI Biotech: Mandatory notification regarding trade of shares172Borkenholm AS has on 29 August 2019 bought 4,000 shares in PCI Biotech Holding ASA ("PCI Biotech") at an average price of NOK 26.90 per share. Borkenholm AS is a related party to board member Hilde...
► Artikel lesen
28.08.PCI Biotech Holding ASA: PCI Biotech: Second quarter and first half 2019 results295Oslo (Norway), 28 August 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its second quarter and first half 2019 result. Please find enclosed the report and...
► Artikel lesen
20.08.PCI Biotech Holding ASA: PCI Biotech: Invitation to second quarter and first half 2019 results presentation232Oslo, Norway, 20 August 2019 - PCI Biotech invites to a presentation of the company's second quarter and first half 2019 results on Wednesday 28 August 2019 at Oslo Cancer Cluster Innovation Park. Time:...
► Artikel lesen
22.07.PCI Biotech Holding ASA: PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company36Oslo (Norway), 22 July 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that they are extending the preclinical research collaboration with an undisclosed top-10...
► Artikel lesen
01.07.PCI Biotech Holding ASA: PCI Biotech to present at IPA World Congress42Oslo, Norway, July 1, 2019 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present the...
► Artikel lesen
21.06.PCI Biotech Holding ASA: PCI Biotech: Employee share option scheme36Oslo, 21 June 2019 In accordance with the authorisation granted by the Annual General Meeting 29 May 2019, the Board of Directors of PCI Biotech Holding ASA has awarded a total of 320,000...
► Artikel lesen
29.05.PCI Biotech Holding ASA: PCI Biotech: Minutes from Annual General Meeting 201943Oslo, 29 May 2019. The Annual General Meeting in PCI Biotech Holding ASA took place today, 29 May 2019. All proposals were resolved by the Annual General Meeting as presented in the notice convening...
► Artikel lesen
28.05.PCI Biotech Holding ASA: PCI Biotech: Disclosure of voting rights for Chairman of the Board24Oslo, 28 May 2019. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall...
► Artikel lesen
23.05.PCI Biotech Holding ASA: PCI Biotech: First patient enrolled in the fimaChem pivotal RELEASE study36Oslo (Norway), 23 May 2019 - PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced first patient...
► Artikel lesen
08.05.PCI Biotech Holding ASA: PCI Biotech: Notice of Annual General Meeting 201941Oslo, Norway 8 May 2019 - The shareholders of PCI Biotech Holding ASA are invited to attend the Annual General Meeting 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday May 29, 10am CEST...
► Artikel lesen
08.05.PCI Biotech Holding ASA: PCI Biotech: First quarter 2019 results36Oslo (Norway), 8 May 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its first quarter 2019 result. Please find enclosed the report and presentation. First...
► Artikel lesen
02.05.PCI Biotech Holding ASA: PCI Biotech: Successful clinical translation of the fimaVacc technology40Oslo (Norway), 2 May 2019 - PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced that the...
► Artikel lesen
30.04.PCI Biotech Holding ASA: PCI Biotech: Invitation to first quarter 2019 result presentation40Oslo, Norway, 30 April 2019 - PCI Biotech invites to a presentation of the company's first quarter 2019 result on Wednesday 8 May 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday 8 May...
► Artikel lesen
09.04.PCI Biotech Holding ASA: PCI Biotech: Annual Report 201827Oslo, Norway, April 9, 2019 The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2018 and the report is attached. The Annual Report 2018 is also available on the company's...
► Artikel lesen
08.04.PCI Biotech Holding ASA: PCI Biotech: Final confirmation of successful safety read-out in the Phase I Extension study24Oslo (Norway), 8 April 2019 - PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced final confirmation...
► Artikel lesen
23.01.XFRA FRA:Deletion of Instruments from XETRA - 23.01.2019-002110The following instruments on XETRA do have their last trading day on 23.01.2019 Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 23.01.2019 TrdMod InstCode Exch ISIN Name InstGrp...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1